4-Hydroxy-6-methyl-2-(trifluoromethyl)quinoline, 97.0%, 5g

1-Chloroisoquinoline-4-boronic acid, 95.0%, 100mg

7-Chloro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 95.0%, 1g

2-Amino-4-(p-tolyl)thiazole>98.0%(GC)(T)25g

3-Bromo-4,6-dichloro-1H-pyrazolo[3,4-d]pyrimidine, 95.0%, 25g

Octahydropyrrolo[3,4-c]pyrrole dihydrochloride, 95.0%, 500mg

GC capillary column ROTI®Cap-5 MS, 30 m, 0.25 mm, 1.00 µm, 1 Piece(s)

(6-Bromoimidazo[1,2-a]pyridin-2-yl)acetic acid, 97.0%, 5g

(S)-1-(4-(trifluoromethyl)phenyl)propan-1-amine, 95%, 1g

8-aminomethyl-3-boc-3-azabicyclo[3.2.1]octane hydrochloride, 95.0%, 1g

tert-Butyl (9-hydroxynonyl)carbamate, 95%, 10g

3-Methoxy-N-methylaniline, 97%, 10g

Lignoceric acid, 98%, 1g